🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How $57M could help this diagnostic test maker take down deadly #sepsis Inflammatix Khosla Ventures Vinod Khosla bizjournals.com/sanfrancisco/n… via San Francisco Business Times

Huge thanks to our team, our funders, and our partners in bringing TriVerity to completion and (hopefully) shortly through FDA clearance! We look forward to making a difference in patient care soon!

Wouldn't have been possible without the members of our lab (students, postdocs, staff) over the last decade trusting me and working hard to make this possible. Special thank you to my mentors (Sorin Draghici, Mark Davis, Atul Butte Mark Musen) for guiding me on this journey.

It’s a lonely job, leading a research group (professor, principal investigator, group leader – whatever you call it). You talk all day with everyone, but you’re mostly alone with the doubts and risks of the biggest decisions. Doesn’t have to be this way and I’d love to change it.

#RHOC star Vicki Gunvalson recently had a near-death experience with #sepsis caused by #pneumonia. Her story is a reminder to recognize early sepsis signs and symptoms and seek immediate medical attention. #SepsisAwarenessMonth rb.gy/1mnycj

Agree with every point Anshul is raising here, especially working with domain experts. We have also seen traditional metrics used to assess performance are not appropriate. Domain experts can help define these metrics.

Interested in learning more about our Stanford Immunology PhD program? Join our open house event for prospective PhD students, designed to facilitate the application process. Fri, Oct 4, 2024 at 1-4pm PT. Register at bit.ly/stanfordimmpre… #stanfordimmunology #phd

Thank you @ACEPNow for another great meeting #ACEP24. We broke our own record for the number of booth visitors and meetings, on top of our oral presentation which was well attended. If you didn’t get a chance to meet up, DM us!

Most of the AI hype folks on here talking about AI and medicine have never diagnosed a patient, have never given treatment, have never counseled a patient. I've practiced medicine and built/tested AI tools. We aren't anywhere close to "replacing doctors".

Today we formally announce the addition of three executives to round out our leadership team, each with extensive experience in bringing MedTech products to market. #diagnostics #HealthcareInnovation See today’s press release: inflammatix.com/inflammatix-ad…

Congrats to all the continued great work at Inflammatix, a great example of translating research concepts started at Stanford Medicine by people like Atul Butte and Purvesh Khatri, and then Tim Sweeney creating a new company working tirelessly toward saving many lives.

Thanks to Red Dot for recognizing TriVerity designers for combining simplicity with advanced machine learning! red-dot.org/project/triver… Products referenced herein are not for sale, is pending FDA clearance, and has no marketing clearance or approval in any jurisdiction.

Catch up with the latest recording of #StanDOM's recent Medical Grand Rounds presentation, "From Computational Analysis to Clinical Practice" with Biomedical Informatics Research's Purvesh Khatri. youtube.com/watch?v=iSbPdq…

Stanford Center for Human Systems Immunology receives a grant from Gates Foundation to focus on diagnosis & vaccination for #InfectiousDiseases. Congrats to #StanDOM's Catherine Blish (BlishLab), Christopher Barnes, Ph.D., Mark Davis, Prasanna Jagannathan & Purvesh Khatri. stan.md/4avt1wc

A new sepsis test developed at Stanford Medicine uses machine learning and publicly available medical datasets from around the world to speed up life-saving diagnoses. scopeblog.stanford.edu/2025/02/05/sep…

For the past decade, Purvesh Khatri and team  have been working on developing blood-based signatures for presence, type, and severity of infection. The signatures were exclusively licensed by Inflammatix, Inc., which a BMI postdoc, Tim Sweeney, and Khatri co-founded 7 years ago.

FDA clears sepsis test from Stanford licensee, Inflammatix , that significantly reduces life-or-death diagnosis time! Purvesh Khatri 🗞️news.stanford.edu/stories/2025/0…

Thanks to Stanford Medicine for interviewing Purvesh Khatri to tell the TriVerity story following its recent FDA clearance, which started in Dr. Khatri's lab with Tim Sweeney a decade ago. Their pioneering work led them and Jonathan Romanowsky to cofound Inflammatix in 2016. Great read!

Our paper "Development of Machine Learning Classifiers for Blood-based Diagnosis and Prognosis of Suspected Acute Infections and Sepsis", presented at the Machine Learning for Health 2024 conference, is now available on PMLR: proceedings.mlr.press/v259/buturovic…